allogeneic fecal microbiota / St. Petersburg State Medical University - LARVOL DELTA

JAK-FMT: Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD (clinicaltrials.gov) - P1/2 | N=2 | Terminated | Sponsor: St. Petersburg State Pavlov Medical University | N=20 ➔ 2 | Trial completion date: Dec 2025 ➔ Nov 2024 | Recruiting ➔ Terminated; Poor recruitment

Combination therapy • Enrollment change • Trial completion date • Trial termination • Bone Marrow Transplantation • Graft versus Host Disease • Immunology • Transplantation

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis (clinicaltrials.gov) - P1 | N=20 | Terminated | Sponsor: St. Petersburg State Pavlov Medical University | Trial completion date: Dec 2024 ➔ Nov 2023 | Recruiting ➔ Terminated | Trial primary completion date: Jun 2023 ➔ Nov 2023; the bio-samples are corrupted for technical reasons

Trial completion date • Trial primary completion date • Trial termination • Bone Marrow Transplantation • CNS Disorders • Multiple Sclerosis • Transplantation

JAK-FMT: Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD (clinicaltrials.gov) - P1/2 | N=20 | Recruiting | Sponsor: St. Petersburg State Pavlov Medical University | Trial completion date: Sep 2025 ➔ Dec 2025 | Trial primary completion date: Feb 2024 ➔ Dec 2024

Trial completion date • Trial primary completion date • Bone Marrow Transplantation • Graft versus Host Disease • Immunology • Transplantation

JAK-FMT: Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD (clinicaltrials.gov) - P1/2 | N=20 | Recruiting | Sponsor: St. Petersburg State Pavlov Medical University | Trial completion date: Sep 2023 ➔ Sep 2025 | Trial primary completion date: Feb 2022 ➔ Feb 2024

Combination therapy • Trial completion date • Trial primary completion date • Bone Marrow Transplantation • Graft versus Host Disease • Immunology • Transplantation

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis (clinicaltrials.gov) - P1; N=20; Recruiting; Sponsor: St. Petersburg State Pavlov Medical University; Trial completion date: Dec 2021 ➔ Dec 2024; Trial primary completion date: Jun 2021 ➔ Jun 2023

Clinical • Trial completion date • Trial primary completion date • CNS Disorders • Multiple Sclerosis • Transplantation • CD4 • CD8